trial

Treatment of Neuroleptic Induced Acute Akathisia With Trazodone

NCTId NCT00659919
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase 4 · Completed
Enrollment 13 (actual)
Sponsored by BeerYaakov Mental Health Center
Primary completion 2003-12
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Phase 4
Status
Completed
Enrollment
13 (actual)
Study type
Interventional
Allocation
Randomized
Model
Crossover
Masking
Double
Start
2000-11
Primary completion
2003-12
Eligibility
ALL · 18 Years · 70 Years

Interventions & indications

Drugs
Trazodone

Sponsors

BeerYaakov Mental Health CenterLead Sponsor

Sites

1 total
Beer Yaacov, Israel

Facts & assertions

4 sourced
Enrollment
13
Phase
PHASE4
Primary Completion Date
2003-12
Status
COMPLETED
relationships
The graph out of here
drug
Trazodone
drug
lead_sponsor
BeerYaakov Mental Health Center
company
indication
Schizophrenia
indication
Schizophrenia
indication